Skip to main content

Featured

Tech Giants Lift Markets as Investors Brace for Fed Decision

Both the S&P 500 and the Nasdaq hit their highest levels in more than a week on Monday. Wall Street finished the day on a strong note, with major U.S. indexes advancing as investors positioned themselves for a pivotal week of corporate earnings and a closely watched Federal Reserve meeting. Market Momentum The S&P 500 and Nasdaq extended their recent winning streak, marking their longest run of gains in weeks. Confidence was fueled largely by heavyweight technology stocks, which continued to attract buyers ahead of their upcoming earnings reports. What’s Driving the Optimism Companies such as Apple, Microsoft, Alphabet, Broadcom, and Meta helped propel the market higher. Their performance has been central to the broader rally, especially as enthusiasm around artificial intelligence remains a dominant theme in tech valuations. Eyes on Earnings and the Fed Investors are now turning their attention to earnings guidance from these major firms, which could determine whether t...
Post a Comment
Read more

article

Labels

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine


Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

This is the second vaccine targeting XBB.1.5 that will be available in this country.

Earlier this month, Health Canada authorized Moderna's updated mRNA vaccine.

Both Pfizer and Moderna's shots are one-dose vaccines for people five years of age and older.

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax.

Novavax’s vaccine has been submitted for consideration for people age 12 years and older.

Labels:

Comments

Post a Comment